National and Kapodistrian University of Athens
Μελέτη του ρόλου του γονιδίου ABCB6 στον ενδοκυττάριο μεταβολισμό του σιδήρου και στη λειτουργία φυσιολογικών και νεοπλασματικών κυττάρων
Abstract
dc:descriptionThe aim of this study was the evaluation of the function of the recently identified ABC transporter, ABCB6. It has been proposed that it plays a role both in intracellular iron metabolism and in multidrug resistance development in human malignancies, but its exact function has not been fully elucidated to date. The Abcb6 transporter resides in the mitochondrion and it has been implicated in iron sulfur (Fe-S) cluster assembly and heme synthesis pathway. We quantified the expression of ABCB6 at the mRNA level following in vitro treatments with substances that alter the intracellular iron concentration and affect the heme biosynthetic pathway. Furthermore we silenced the expression of the ABCB6 gene and assessed the Fe-S cluster assembly proccess. Our results show that ABCB6 expression is controlled at the transcriptional level and is affected by intracellular iron levels, but we were not able to define the exact mechanism or pathway in which the gene participates. Silencing ot the gene did not affect Fe-S cluster assembly in the cytoplasm. Most likely it seems that ABCB6 plays a role in the heme biosynthetic pathway, as its expression is coordinated with changes in heme synthesis. The second isoform of Abcb6 is located in the plasma membrane and elevated expression of ABCB6 has been associated with resistance development to chemotherapeutic drugs. We quantified the expression of ABCB6 and the well studied transporters ABCB1 and ABCG2 in patients with newly diagnosed acute myeloid leukemia (AML). Expression data were correlated with other clinical parameters, response and disease outcome. There was a strong correlation between ABCB6 and ABCB1 expression and achievement of complete remission in AML patients. Both genes were overexpressed in primary resistant patients compared to responders. There was no correlation between ABCB6, ABCB1 and ABCG2 expression and relapse, disease free survival, overall survival, as well as prognostic factors, such as age, karyotype and FLT3-Internal Tandem Duplication. Expression of the three genes in samples obtained after induction chemotherapy was not correlated to achievement of remission. Only ABCG2 was found significantly overexpressed in patients which developed AML from preceeding myelodysplastic syndrome compared to de novo AML patients. Finally, short term treatment of the AML cell line HL-60 with the chemotherapeutic drugs Etoposide, Idarubicin and Cytarabine resulted in ABCB6 upregulation after exposure to Etoposide.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2010
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Palaiologou, Danai
- Παλαιολόγου, Δανάη
Subjects
dc:subject × 13Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/24321